Daniel Newman Mendelson, Director at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 5,000 shares at $5.51 ($28K) on 2023-09-21, disclosed to the SEC on 2023-09-25.
Open-market purchase of $28k CSBR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| CSBR | BUY | 2024-01-11 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-10 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-09 | $6K | — | Filing → |